Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 393201 - 393220 out of 563611 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (L01EG01) temsirolimus | Torisel 30 mg | , Hetteglass, Konsentrat og væske til infusjonsvæske, oppløsning, 30 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Lymphoma, Mantle-Cell | PfizerEuropeMAEEIG(1) |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Afinitor 10 mg | 30 stk, Blisterpakning, Tablett, 10 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisEuropharmLimited(1) |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Votubia 10 mg | 30 stk, Blisterpakning, Tablett, 10 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Tuberous Sclerosis | NovartisEuropharmLimited(1) |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Votubia 2 mg | 30 stk, Blisterpakning, Dispergerbar tablett, 2 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Tuberous Sclerosis | NovartisEuropharmLimited(1) |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Afinitor 2,5 mg | 30 stk, Blisterpakning, Tablett, 2,5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisEuropharmLimited(1) |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Afinitor 2,5 mg | 30 stk, Blisterpakning, Tablett, 2,5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | AbacusMedicineA/S |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Afinitor 2,5 mg | 30 stk, Blisterpakning, Tablett, 2,5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | OrifarmAS |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Votubia 2,5 mg | 30 stk, Blisterpakning, Tablett, 2,5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Tuberous Sclerosis | NovartisEuropharmLimited(1) |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Votubia 3 mg | 30 stk, Blisterpakning, Dispergerbar tablett, 3 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Tuberous Sclerosis | NovartisEuropharmLimited(1) |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Afinitor 5 mg | 30 stk, Blisterpakning, Tablett, 5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisEuropharmLimited(1) |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Votubia 5 mg | 30 stk, Blisterpakning, Tablett, 5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Tuberous Sclerosis | NovartisEuropharmLimited(1) |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Votubia 5 mg | 30 stk, Blisterpakning, Dispergerbar tablett, 5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Tuberous Sclerosis | NovartisEuropharmLimited(1) |
| Norway | (L01EH01) lapatinib | Lapatinib Newbury 250 mg | 84 stk, Blisterpakning, Tablett, filmdrasjert, 250 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | NewburyPharmaceuticalsAB |
| Norway | (L01EH01) lapatinib | Tyverb 250 mg | 84 stk, Boks av plast, Tablett, 250 mg , Boks av plast | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisEuropharmLimited(1) |
| Norway | (L01EH01) lapatinib | Tyverb 250 mg | 70 stk, Blisterpakning, Tablett, 250 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisEuropharmLimited(1) |
| Norway | (L01EH02) neratinib | Nerlynx 40 mg | 180 stk, Beholder av plast, Tablett, filmdrasjert, 40 mg , Beholder av plast | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PierreFabreMedicament |
| Norway | (L01EH03) tucatinib | Tukysa 150 mg | 84 stk, Blisterpakning, Tablett, filmdrasjert, 150 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Neoplasm Metastasis | OrifarmAS |
| Norway | (L01EH03) tucatinib | Tukysa 50 mg | 88 stk, Blisterpakning, Tablett, filmdrasjert, 50 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Neoplasm Metastasis | OrifarmAS |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Afinitor 10 mg | 30 stk, Blisterpakning, Tablett, 10 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisEuropharmLimited(1) |
| Norway | (L01EG02) everolimus (neoplastic diseases) | Votubia 2 mg | 30 stk, Endoseblisterpakning, Dispergerbar tablett, 2 mg , Endoseblisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Tuberous Sclerosis | OrifarmAS |
Pages
